Literature DB >> 33181888

Postoperative persistent fever may be a risk factor for hydrocephalus in hemispherical disconnection surgery.

Toshiki Nozaki1, Ayataka Fujimoto2, Shimpei Baba1, Hideo Enoki1, Tohru Okanishi1.   

Abstract

INTRODUCTION: Hemispherical disconnection surgery such as hemispherotomy or posterior quadrant disconnection (PQD) surgery sometimes induces hydrocephalus. We postulated that some risk factors for postoperative hydrocephalus can be managed perioperatively. The purpose of this study was to clarify and statistically analyze perioperative risk factors for postoperative progressive hydrocephalus.
METHODS: We reviewed patients who underwent hemispherotomy or PQD. We compared patients with and without progressive hydrocephalus with multivariate and univariate logistic regression analysis to identify risk factors for hydrocephalus.
RESULTS: Twenty-four patients underwent hemispherectomy or PQD (age: 25 days-45 years old, mean: 13.3 years, median: 8 years, standard deviation: 13.9 years, 14 males). Among them, five patients (21%) required hydrocephalus treatment. Persistent fever was a risk factor for progressive hydrocephalus (multivariate analysis: p = 0.024, univariate analysis: p < 0.001).
CONCLUSION: Postoperative persistent fever may be a manageable risk factor for postoperative hydrocephalus in hemispherotomy and PQD surgery.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aseptic ventriculitis; Hemispherotomy; Hydrocephalus; Inflammation; Posterior quadrant disconnection surgery; Postoperative persistent fever

Mesh:

Year:  2020        PMID: 33181888     DOI: 10.1016/j.yebeh.2020.107466

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  1 in total

1.  Postoperative Pneumocephalus on Computed Tomography Might Predict Post-Corpus Callosotomy Chemical Meningitis.

Authors:  Ayataka Fujimoto; Keisuke Hatano; Toshiki Nozaki; Keishiro Sato; Hideo Enoki; Tohru Okanishi
Journal:  Brain Sci       Date:  2021-05-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.